United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,557,100 | 1,697,200 | 1,207,700 | 961,200 | 894,800 |
| Marketable Securities | 1,363,200 | 1,569,800 | 1,786,400 | 1,877,500 | 1,035,900 |
| Receivables | 350,200 | 279,300 | 278,900 | 220,400 | 198,700 |
| Inventories | 183,100 | 157,900 | 111,800 | 102,000 | 93,800 |
| Other current assets | 248,900 | 169,700 | 166,200 | 219,200 | 100,400 |
| TOTAL | $3,702,500 | $3,873,900 | $3,551,000 | $3,380,300 | $2,323,600 |
| Non-Current Assets | |||||
| PPE Net | 1,729,700 | 1,222,400 | 1,045,400 | 861,500 | 780,900 |
| Investments And Advances | 1,776,700 | 1,475,300 | 1,909,800 | 1,316,200 | 1,649,900 |
| Other Non-Current Assets | 671,100 | 792,400 | 660,800 | 486,500 | 414,700 |
| TOTAL | $4,177,500 | $3,490,100 | $3,616,000 | $2,664,200 | $2,845,500 |
| Total Assets | $7,880,000 | $7,364,000 | $7,167,000 | $6,044,500 | $5,169,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 300,000 | 400,000 | 0 | N/A |
| Accounts payable and accrued liabilities | 488,000 | 344,500 | 298,000 | 229,900 | 174,600 |
| Other current liabilities | 72,600 | 93,600 | 106,400 | 113,300 | 130,800 |
| TOTAL | $560,600 | $738,100 | $804,400 | $343,200 | $305,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 300,000 | 800,000 | 800,000 |
| Other Non-Current Liabilities | 223,200 | 181,900 | 77,800 | 104,600 | 104,800 |
| TOTAL | $223,200 | $181,900 | $377,800 | $904,600 | $904,800 |
| Total Liabilities | $783,800 | $920,000 | $1,182,200 | $1,247,800 | $1,210,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,828 | 44,912 | 47,059 | 46,302 | 45,132 |
| Common Shares | 800 | 800 | 700 | 700 | 700 |
| Retained earnings | 8,556,900 | 7,222,200 | 6,027,100 | 5,042,300 | 4,315,000 |
| Other shareholders' equity | 500 | -2,900 | -13,000 | -55,700 | -23,200 |
| TOTAL | $7,096,200 | $6,444,000 | $5,984,800 | $4,796,700 | $3,958,900 |
| Total Liabilities And Equity | $7,880,000 | $7,364,000 | $7,167,000 | $6,044,500 | $5,169,100 |